SATURDAY, 28 MAY 2022 |
|
ADULT & PAEDIATRIC NEPHROLOGY COMBINED VENUE: MR 12 |
RCSSA VENUE: HALL 3A |
|
Chairpersons Kwazi Ndlovu & Brian Rayner |
Chairpersons David Mphuthi & Jonathan Maree |
08:00-08:30 |
APOL1 variants in CKD and kidney transplant Jeffrey Kopp (USA) |
Ethics Lecture: Issues relating to the employment of practitioners M Kwinda (SA) |
08:30-09:00 |
COVID-19 - from pandemic to endemic Shoyab Wadee (SA) |
Improving quality renal care through health literacy testing Elsabet Van Rensburg (SA) |
09:00-09:30 |
Lung-kidney interactions in critically ill patients: Lessons from COVID 19 Claudio Ronco (Italy) |
Incidence, associated risk factors and outcomes of pregnancy-related acute kidney injury in North Central, Nigeria Bala Waziri (Nigeria) |
09:30-09:40 |
The causes of hypertension in children less than 18 years at Red Cross War Memorial Children's Hospital Bonisiwe Chauke-Makamba (SA) |
Cultural practices and diet adherence of patients living on haemodialysis Verosha Ramkelawan (SA) |
09:40-09:50 |
Shedding of HIV-1 into peritoneal dialysis effluent and associated risk factors Teboho Mooko (SA) |
09:50-10:00 |
Peritoneal dialysis-related peritonitis and outcomes in a tertiary level hospital in Johannesburg Midhu Sunnyraj (SA) |
10:00-10:30 |
POSTER VIEWING & COFFEE BREAK - VENUE: EXHIBITION HALL - HALL 2CDE |
|
ADULT & PAEDIATRIC NEPHROLOGY COMBINED VENUE: MR 12 |
RCSSA VENUE: HALL 3A |
|
Chairpersons Mignon McCulloch & Razeen Davids |
Chairpersons Vusi Mkhatshwa & Thembi Nteta |
10:30-11:00 |
Monoclonal antibodies in immunologic glomerular diseases David Jayne (UK) |
The South African national consensus statement on Renal Supportive Care - a signpost for the future Frank Brennan (Australia) |
11:00-11:30 |
Can you transplant into a Bad Bladder? Jo Clothier (UK) |
Ethics Lecture: Criminal prosecution of practitioners: Unprofessional conduct vs. criminal conduct M Kwinda (SA) |
11:30-12:00 |
Building consensus around controversial aspects of managing hyperkalaemia Yazied Chothia (SA) |
Pain management of patients with chronic renal failure: A case study of patients in a private renal facility Shamanie Govender (SA) |
12:00-12:05 |
COVID-19-related AKI and dialysis: What are the outcomes in South Africa? Wesley van Hougenhouck-Tulleken (SA) |
COVID-19 in dialysis patients, A South African experience Chevon Clark (SA) |
12:05-12:10 |
Successful management of a Jehovah's Witness patient with ANCA-associated vasculitis following Pfizer- BioNTech COVID-19 Vaccine, declining blood products Wilhelm Herbst (SA) |
12:10-12:15 |
Ethical Culture, Ethical Leadership and Turnover Intention in the Private Sector Nicola Ferreira (SA) |
12:15-12:20 |
Comparison of quality of life in patients with advanced chronic kidney disease undergoing haemodialysis, peritoneal dialysis and conservative management Neelu Mathew (SA) |
12:20-12:25 |
Demographic and clinical profile of black patients with chronic kidney disease attending Charlotte Maxeke Johannesburg Academic Hospital (CMJAH) in Johannesburg, South Africa Alfred Meremo (SA) / Saraladevi Naicker (SA) |
12:25-12:30 |
Assessing the hydration status of South African children on chronic haemodialysis: A comparison of techniques Neliswa Sinezeliwe Mbatha (SA) |
12:30-12:35 |
The evolving spectrum of renal histology in HIV positive patients in South Africa in the antiretroviral and tuberculosis era Nicola Wearne (SA) |
Haemodialysis practitioners' knowledge and practice on prevention of haemodialysis vascular catheter-related infections Siyanda Alex Ngema (SA) |
12:35-13:00 |
Questions and Answers |
13:00-14:00 |
NOVO NORDISK LUNCH SYMPOSIUMVENUE: MR 12
Insulin Therapy in Renal Disease Dr Alkesh Magan (Specialist Physician & Endocrinologist, Sandton Mediclinic) |
13:00-14:00 |
LUNCH BREAK - VENUE: EXHIBITION HALL - HALL 2CDE - SPONSORED BY ADCOCK INGRAM CRITICAL CARE |
|
PLENARY I VENUE: HALL 3A |
|
Chairpersons Mark Padavattan & Shoyab Wadee |
14:00-14:30 |
The management of Inborn Errors of Metabolism: Medical therapy and RRT Stefano Picca (Italy) |
14:30-15:00 |
Improving Quality of Care in Haemodialysis: Lessons from the Standardized Outcomes in Nephrology (SONG) initiative Tushar Vachharajani (USA) |
15:00-15:30 |
Infections and the kidney Wesam Ismail (Egypt) |
15:30-16:00 |
COFFEE BREAK - VENUE: EXHIBITION HALL - HALL 2CDE |
|
ADULT & PAEDIATRIC NEPHROLOGY COMBINED VENUE: MR 12 |
RCSSA VENUE: HALL 3A |
|
Chairpersons Graham Paget & Mduduzi Mashabane |
Chairpersons Chevon Clark & Stephanie Viljoen |
16:00-16:30 |
COVID-19 - opportunities for CKD in the broader national noncommunicable chronic disease agenda Vivek Jha (India) |
Record review of post-haemodialysis blood results to assess adherence to guidelines for End Stage Renal Disease Yolinda Louise van der Nest (SA) |
16:30-17:00 |
HIV CKD: Clinicopathologic correlations and outcomes Nina Diana (SA) |
Monitoring factors influencing clotting during chronic haemodialysis therapy Nthabiseng Patricia Melato (SA) |
17:00-17:10 |
The impact of diabetes and hypertension on renal allograft survival-a single centre study Sumesh Padayachee (SA) |
Patients' perspectives on fluid management on a haemodialysis programme Xolisa Xolo (SA) |
17:10-17:20 |
COVID-19 vaccine hesitancy in patients attending an outpatient dialysis unit in Johannesburg, South Africa Zaheera Cassimjee (SA) |
17:20-17:30 |
Incidence and one-year survival in elderly South Africans starting kidney replacement therapy Thabiet Jardine (SA) |
17:30-17:35 |
A retrospective study of the epidemiology and outcome of patients with dialysis-requiring acute kidney injury at Helen Joseph Hospital, Johannesburg, South Africa Yashika Naidu (SA) |
|
17:35-17:40 |
Chronic kidney disease among treatment-naïve HIV infected patients in Kano Nigeria Aliyu Abdu (Nigeria) |
|
17:40-17:45 |
Prevalence and Determinants of Endothelial dysfunction among HIV-positive, ART-treated adults at the Aminu Kano Teaching Hospital, Kano, Nigeria Aishatu Nalado (Nigeria) |
|
17:45-17:50 |
Questions and Answers |
|
17:45-19:30 |
|
RCSSA AGM |